Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Liabilities and Shareholders Equity (2016 - 2025)

Pulmatrix (PULM) has disclosed Liabilities and Shareholders Equity for 12 consecutive years, with $4.1 million as the latest value for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity fell 58.37% to $4.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $23.3 million through Dec 2025, down 65.51% year-over-year, with the annual reading at $4.1 million for FY2025, 58.37% down from the prior year.
  • Liabilities and Shareholders Equity hit $4.1 million in Q4 2025 for Pulmatrix, down from $5.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $69.8 million in Q1 2021 to a low of $4.1 million in Q4 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $33.5 million across 5 years, with a median of $35.0 million in 2023.
  • Biggest five-year swings in Liabilities and Shareholders Equity: soared 126.62% in 2021 and later crashed 73.51% in 2025.
  • Year by year, Liabilities and Shareholders Equity stood at $58.8 million in 2021, then tumbled by 30.37% to $41.0 million in 2022, then fell by 17.08% to $34.0 million in 2023, then crashed by 70.72% to $9.9 million in 2024, then crashed by 58.37% to $4.1 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for PULM at $4.1 million in Q4 2025, $5.0 million in Q3 2025, and $6.2 million in Q2 2025.